Therapeutic effects of mesenchymal stem cells on renal ischemia-reperfusion injury: A matter of genetic transfer?

Stem Cell Research and Therapy

Volumn 4, Issue 5, 2013, Pages

  Bruno, Stefania ^a   Bussolati, Benedetta ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SCATTER FACTOR; SOMATOMEDIN C RECEPTOR;

FIBROGENESIS; GENE TRANSFER; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; MESENCHYMAL STEM CELL; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; TISSUE REPAIR; WHARTON JELLY;

EID: 84878632892     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt205     Document Type: Review

References (10)

1. Human Wharton jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells. Du T, Zou X, Cheng J, Wu S, Zhong L, Ju G, Zhu J, Liu G, Zhu Y, Xia S, Stem Cell Res Ther 2013 4 59
2. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C, Am J Cancer Res 2011 1 98 110 21969178
3. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G, J Am Soc Nephrol 2009 20 1053 1067 10.1681/ASN.2008070798 19389847
4. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, Tetta C, Camussi G, PLoS One 2012 7 33115 10.1371/journal.pone.0033115 22431999
5. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, Camussi G, Nephrol Dial Transplant 2011 26 1474 1483 10.1093/ndt/gfr015 21324974
6. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. He J, Wang Y, Sun S, Yu M, Wang C, Pei X, Zhu B, Wu J, Zhao W, Nephrology 2012 17 493 500 10.1111/j.1440-1797.2012.01589.x 22369283
7. Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through pcrine effects in rats. Reis LA, Borges FT, Simoes MJ, Borges AA, Sinigaglia-Coimbra R, Schor N, PLoS One 2012 7 44092 10.1371/journal.pone.0044092 22970165
8. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Tomasoni S, Longaretti L, Rota C, Morigi M, Conti S, Gotti E, Capelli C, Introna M, Remuzzi G, Benigni A, Stem Cells Dev 2013 22 772 780 10.1089/scd.2012.0266 23082760
9. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM, Pasterkamp G, de Kleijn DP, Lim SK, Stem Cell Res 2010 4 214 222 10.1016/j.scr.2009.12.003 20138817
10. Marrow cell genetic phenotype change induced by human lung cancer cells. Del Tatto M, Ng T, Aliotta JM, Colvin GA, Dooner MS, Berz D, Dooner GJ, Papa EF, Hixson DC, Ramratnam B, Aswad BI, Sears EH, Reagan J, Quesenberry PJ, Exp Hematol 2011 39 1072 1080 10.1016/j.exphem.2011.08.008 21864488